Skip to main content
Erschienen in: Journal of Nephrology 5/2019

01.10.2019 | Review

Incremental hemodialysis, a valuable option for the frail elderly patient

verfasst von: Carlo Basile, Francesco Gaetano Casino, Filippo Aucella

Erschienen in: Journal of Nephrology | Ausgabe 5/2019

Einloggen, um Zugang zu erhalten

Abstract

Management of older people on dialysis requires focus on the wider aspects of aging as well as dialysis. Recognition and assessment of frailty is vital in changing our approach in elderly patients. Current guidelines in dialysis have a limited evidence base across all age group, but particularly the elderly. We need to focus on new priorities of care when we design guidelines “for people not diseases”. Patient-centered goal-directed therapy, arising from shared decision-making between physician and patient, should allow adaption of the dialysis regime. Hemodialysis (HD) in the older age group can be complicated by intradialytic hypotension, prolonged time to recovery, and access-related problems. There is increasing evidence relating to the harm associated with the delivery of standard thrice-weekly HD. Incremental HD has a lower burden of treatment. There appears to be no adverse clinical effects during the first years of dialysis in presence of a significant residual kidney function. The advantages of incremental HD might be particularly important for elderly patients with short life expectancy. There is a need for more research into specific topics such as the assessment of the course of frailty with progression of chronic kidney disease and after dialysis initiation, the choice of dialysis modality impacting on the trajectory of frailty, the timing of dialysis initiation impacting on frailty or on other outcomes. In conclusion, understanding each individual’s goals of care in the context of his or her life experience is particularly important in the elderly, when overall life expectancy is relatively short, and life experience or quality of life may be the priority.
Literatur
2.
Zurück zum Zitat Orimo H, Ito H, Suzuki T et al (2006) Reviewing the definition of “elderly”. Geriatrics Gerontol Int 6:149–158CrossRef Orimo H, Ito H, Suzuki T et al (2006) Reviewing the definition of “elderly”. Geriatrics Gerontol Int 6:149–158CrossRef
3.
Zurück zum Zitat Centers for Disease Control and Prevention (2003) Public health and aging: trends in aging—United States and worldwide. JAMA 289:1371–1373CrossRef Centers for Disease Control and Prevention (2003) Public health and aging: trends in aging—United States and worldwide. JAMA 289:1371–1373CrossRef
4.
Zurück zum Zitat Coresh J, Selvin E, Stevens LA et al (2007) Prevalence of chronic kidney disease in the United States. JAMA 298:2038–2047CrossRefPubMed Coresh J, Selvin E, Stevens LA et al (2007) Prevalence of chronic kidney disease in the United States. JAMA 298:2038–2047CrossRefPubMed
5.
6.
Zurück zum Zitat Arora P, Vasa P, Brenner D et al (2013) Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey. CMAJ 185:E417–E423CrossRefPubMedPubMedCentral Arora P, Vasa P, Brenner D et al (2013) Prevalence estimates of chronic kidney disease in Canada: results of a nationally representative survey. CMAJ 185:E417–E423CrossRefPubMedPubMedCentral
7.
Zurück zum Zitat Bash LD, Astor BC, Coresh J (2010) Risk of incident ESRD: a comprehensive look at cardiovascular risk factors and 17 years of follow-up in the atherosclerosis risk in communities (ARIC) study. Am J Kidney Dis 55:31–41CrossRefPubMed Bash LD, Astor BC, Coresh J (2010) Risk of incident ESRD: a comprehensive look at cardiovascular risk factors and 17 years of follow-up in the atherosclerosis risk in communities (ARIC) study. Am J Kidney Dis 55:31–41CrossRefPubMed
8.
Zurück zum Zitat Gansevoort RT, Matsushita K, van der Velde M et al (2011) Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int 80:93–104CrossRefPubMedPubMedCentral Gansevoort RT, Matsushita K, van der Velde M et al (2011) Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts. Kidney Int 80:93–104CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Anderson S, Halter JB, Hazzard WR et al (2009) Prediction, progression, and outcomes of chronic kidney disease in older adults. J Am Soc Nephrol 20:1199–1209CrossRefPubMed Anderson S, Halter JB, Hazzard WR et al (2009) Prediction, progression, and outcomes of chronic kidney disease in older adults. J Am Soc Nephrol 20:1199–1209CrossRefPubMed
12.
Zurück zum Zitat United States Renal Data System (2014) Annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Incidence, prevalence, patient characteristics, and treatment modalities. Am J Kidney Dis 63(Suppl 1):e215–e228 United States Renal Data System (2014) Annual data report: atlas of chronic kidney disease and end-stage renal disease in the United States. Incidence, prevalence, patient characteristics, and treatment modalities. Am J Kidney Dis 63(Suppl 1):e215–e228
14.
Zurück zum Zitat Lattanzio F, Corsonello A, Abbatecola AM et al (2012) Relationship between renal function and physical performance in elderly hospitalized patients. Rejuvenation Res 15:545–552CrossRefPubMedPubMedCentral Lattanzio F, Corsonello A, Abbatecola AM et al (2012) Relationship between renal function and physical performance in elderly hospitalized patients. Rejuvenation Res 15:545–552CrossRefPubMedPubMedCentral
15.
Zurück zum Zitat Corsonello A, Fusco S, Bustacchini S et al (2016) Special considerations for the treatment of chronic kidney disease in the elderly. Expert Rev Clin Pharmacol 9:727–737CrossRefPubMed Corsonello A, Fusco S, Bustacchini S et al (2016) Special considerations for the treatment of chronic kidney disease in the elderly. Expert Rev Clin Pharmacol 9:727–737CrossRefPubMed
16.
Zurück zum Zitat Walker SR, Gill K, Macdonald K et al (2013) Association of frailty and physical function in patients with non-dialysis CKD: a systematic review. BMC Nephrol 14:228CrossRefPubMedPubMedCentral Walker SR, Gill K, Macdonald K et al (2013) Association of frailty and physical function in patients with non-dialysis CKD: a systematic review. BMC Nephrol 14:228CrossRefPubMedPubMedCentral
17.
Zurück zum Zitat Fraser SD, Roderick PJ, May CR et al (2015) The burden of comorbidity in people with chronic kidney disease stage 3: a cohort study. BMC Nephrol 16:193CrossRefPubMedPubMedCentral Fraser SD, Roderick PJ, May CR et al (2015) The burden of comorbidity in people with chronic kidney disease stage 3: a cohort study. BMC Nephrol 16:193CrossRefPubMedPubMedCentral
18.
Zurück zum Zitat Formiga F, Ferrer A, Sanz H et al (2013) Patterns of comorbidity and multimorbidity in the oldest old: the Octabaix study. Eur J Intern Med 24:40–44CrossRefPubMed Formiga F, Ferrer A, Sanz H et al (2013) Patterns of comorbidity and multimorbidity in the oldest old: the Octabaix study. Eur J Intern Med 24:40–44CrossRefPubMed
19.
Zurück zum Zitat Clegg A, Young J, Iliff S et al (2013) Frailty in elderly people. Lancet 381:752–762CrossRef Clegg A, Young J, Iliff S et al (2013) Frailty in elderly people. Lancet 381:752–762CrossRef
20.
Zurück zum Zitat Kojima G (2017) Prevalence of frailty in end-stage renal disease: a systematic review and meta-analysis. Int Urol Nephrol 49:1989–1997CrossRefPubMed Kojima G (2017) Prevalence of frailty in end-stage renal disease: a systematic review and meta-analysis. Int Urol Nephrol 49:1989–1997CrossRefPubMed
21.
Zurück zum Zitat Musso CG, Jauregui J, Macías-Núñez J (2015) Frailty phenotype and chronic kidney disease: a review of the literature. Int Urol Nephrol 47:1801–1807CrossRefPubMed Musso CG, Jauregui J, Macías-Núñez J (2015) Frailty phenotype and chronic kidney disease: a review of the literature. Int Urol Nephrol 47:1801–1807CrossRefPubMed
22.
Zurück zum Zitat Johansen KL, Chertow GM, Jin C et al (2007) Significance of frailty among dialysis patients. J Am Soc Nephrol 18:2960–2967CrossRefPubMed Johansen KL, Chertow GM, Jin C et al (2007) Significance of frailty among dialysis patients. J Am Soc Nephrol 18:2960–2967CrossRefPubMed
23.
Zurück zum Zitat Bao Y, Dalrymple L, Chertow GM et al (2012) Frailty, dialysis initiation, and mortality in end-stage renal disease. Arch Intern Med 172:1071–1077CrossRefPubMedPubMedCentral Bao Y, Dalrymple L, Chertow GM et al (2012) Frailty, dialysis initiation, and mortality in end-stage renal disease. Arch Intern Med 172:1071–1077CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Fried LP, Hadley EC, Walston JD et al (2005) From bedside to bench: research agenda for frailty. Sci Aging Knowl Environ 31:24 Fried LP, Hadley EC, Walston JD et al (2005) From bedside to bench: research agenda for frailty. Sci Aging Knowl Environ 31:24
25.
Zurück zum Zitat Swidler M (2013) Considerations in starting a patient with advanced frailty on dialysis: complex biology meets challenging ethics. Clin J Am Soc Nephrol 8:1421–1428CrossRefPubMedPubMedCentral Swidler M (2013) Considerations in starting a patient with advanced frailty on dialysis: complex biology meets challenging ethics. Clin J Am Soc Nephrol 8:1421–1428CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Farrington K, Covic A, Aucella F et al (2016) ERBP guideline development group. Clinical Practice Guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR < 45 mL/min/173 m2). Nephrol Dial Transplant 31(Suppl 2):ii1–ii66CrossRefPubMed Farrington K, Covic A, Aucella F et al (2016) ERBP guideline development group. Clinical Practice Guideline on management of older patients with chronic kidney disease stage 3b or higher (eGFR < 45 mL/min/173 m2). Nephrol Dial Transplant 31(Suppl 2):ii1–ii66CrossRefPubMed
27.
Zurück zum Zitat O’Hare AM, Choi AI, Bertenthal D et al (2007) Age affects outcomes in chronic kidney disease. J Am Soc Nephrol 18:2758–2765CrossRefPubMed O’Hare AM, Choi AI, Bertenthal D et al (2007) Age affects outcomes in chronic kidney disease. J Am Soc Nephrol 18:2758–2765CrossRefPubMed
28.
Zurück zum Zitat Urquhart-Secord R, Craig JC, Hemmelgarn B et al (2016) Patient and caregiver priorities for outcomes in hemodialysis: an international nominal group technique study. Am J Kidney Dis 68:444–454CrossRefPubMed Urquhart-Secord R, Craig JC, Hemmelgarn B et al (2016) Patient and caregiver priorities for outcomes in hemodialysis: an international nominal group technique study. Am J Kidney Dis 68:444–454CrossRefPubMed
29.
Zurück zum Zitat Aucella F, Stoico L, Cicchella A et al (2012) Comprehensive geriatric assessment in the hemodialysis elderly population. J Nephrol 25(Suppl 19):S85–S89CrossRefPubMed Aucella F, Stoico L, Cicchella A et al (2012) Comprehensive geriatric assessment in the hemodialysis elderly population. J Nephrol 25(Suppl 19):S85–S89CrossRefPubMed
30.
Zurück zum Zitat Bansal N, Katz R, De Boer IH et al (2015) Development and validation of a model to predict 5-year risk of death without ESRD among older adults with CKD. Clin J Am Soc Nephrol 10:363–371CrossRefPubMedPubMedCentral Bansal N, Katz R, De Boer IH et al (2015) Development and validation of a model to predict 5-year risk of death without ESRD among older adults with CKD. Clin J Am Soc Nephrol 10:363–371CrossRefPubMedPubMedCentral
32.
Zurück zum Zitat Mandel EI, Bernacki RE, Block SD (2017) Serious illness conversations in ESRD. Clin J Am Soc Nephrol 12:854–863CrossRefPubMed Mandel EI, Bernacki RE, Block SD (2017) Serious illness conversations in ESRD. Clin J Am Soc Nephrol 12:854–863CrossRefPubMed
33.
Zurück zum Zitat Visser A, Dijkstra GJ, Kuiper D et al (2009) Accepting or declining dialysis: considerations taken into account by elderly patients with end-stage renal disease. J Nephrol 22:794–799PubMed Visser A, Dijkstra GJ, Kuiper D et al (2009) Accepting or declining dialysis: considerations taken into account by elderly patients with end-stage renal disease. J Nephrol 22:794–799PubMed
34.
Zurück zum Zitat Raghavan D, Holley JL (2016) Conservative care of the elderly CKD patient: a practical guide. Adv Chronic Kidney Dis 23:51–56CrossRefPubMed Raghavan D, Holley JL (2016) Conservative care of the elderly CKD patient: a practical guide. Adv Chronic Kidney Dis 23:51–56CrossRefPubMed
35.
Zurück zum Zitat Brown EA, Finkelstein FO, Iyasere OU et al (2017) Peritoneal or hemodialysis for the frail elderly patient, the choice of 2 evils? Kidney Int 91:294–303CrossRefPubMed Brown EA, Finkelstein FO, Iyasere OU et al (2017) Peritoneal or hemodialysis for the frail elderly patient, the choice of 2 evils? Kidney Int 91:294–303CrossRefPubMed
38.
Zurück zum Zitat Kurella TM, Covinsky KE, Chertow GM et al (2009) Functional status of elderly adults before and after initiation of dialysis. N Engl J Med 361:1539–1547CrossRef Kurella TM, Covinsky KE, Chertow GM et al (2009) Functional status of elderly adults before and after initiation of dialysis. N Engl J Med 361:1539–1547CrossRef
39.
Zurück zum Zitat Jassal SV, Chiu E, Hladunewich M (2009) Loss of independence in patients starting dialysis at 80 years of age or older. N Engl J Med 361:1612–1613CrossRefPubMed Jassal SV, Chiu E, Hladunewich M (2009) Loss of independence in patients starting dialysis at 80 years of age or older. N Engl J Med 361:1612–1613CrossRefPubMed
40.
Zurück zum Zitat Cooper BA, Branley P, Bulfone L, for the IDEAL Study et al (2010) A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med 363:609–619CrossRefPubMed Cooper BA, Branley P, Bulfone L, for the IDEAL Study et al (2010) A randomized, controlled trial of early versus late initiation of dialysis. N Engl J Med 363:609–619CrossRefPubMed
41.
Zurück zum Zitat Basile C, Lomonte C (2012) Kt/V urea does not tell it. Nephrol Dial Transplant 27:1284–1287CrossRefPubMed Basile C, Lomonte C (2012) Kt/V urea does not tell it. Nephrol Dial Transplant 27:1284–1287CrossRefPubMed
42.
Zurück zum Zitat Corbett RW, Brown EA (2018) Conventional dialysis in the elderly. how lenient should our guidelines be? Semin Dial 31:607–611CrossRefPubMed Corbett RW, Brown EA (2018) Conventional dialysis in the elderly. how lenient should our guidelines be? Semin Dial 31:607–611CrossRefPubMed
43.
Zurück zum Zitat Wong S, Kreuter W, O’Hare AM (2014) Healthcare intensity at initiation of chronic dialysis among older adults. J Am Soc Nephrol 25:143–149CrossRefPubMed Wong S, Kreuter W, O’Hare AM (2014) Healthcare intensity at initiation of chronic dialysis among older adults. J Am Soc Nephrol 25:143–149CrossRefPubMed
44.
Zurück zum Zitat Chazot C, Charra B, Van Vo C et al (1999) The Janus-faced aspect of “dry weight”. Nephrol Dial Transplant 14:121–124CrossRefPubMed Chazot C, Charra B, Van Vo C et al (1999) The Janus-faced aspect of “dry weight”. Nephrol Dial Transplant 14:121–124CrossRefPubMed
45.
Zurück zum Zitat McIntyre CW, Burton JO, Selby NM et al (2008) Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow. Clin J Am Soc Nephrol 3:19–26CrossRefPubMedPubMedCentral McIntyre CW, Burton JO, Selby NM et al (2008) Hemodialysis-induced cardiac dysfunction is associated with an acute reduction in global and segmental myocardial blood flow. Clin J Am Soc Nephrol 3:19–26CrossRefPubMedPubMedCentral
46.
Zurück zum Zitat Costa AS, Tiffin-Richards FE, Holschbach B et al (2014) Clinical predictors of individual cognitive fluctuations in patients undergoing hemodialysis. Am J Kidney Dis 64:434–442CrossRefPubMed Costa AS, Tiffin-Richards FE, Holschbach B et al (2014) Clinical predictors of individual cognitive fluctuations in patients undergoing hemodialysis. Am J Kidney Dis 64:434–442CrossRefPubMed
47.
Zurück zum Zitat Rayner HC, Zepel L, Fuller DS et al (2014) Recovery time, quality of life, and mortality in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 64:86–94CrossRefPubMedPubMedCentral Rayner HC, Zepel L, Fuller DS et al (2014) Recovery time, quality of life, and mortality in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 64:86–94CrossRefPubMedPubMedCentral
49.
Zurück zum Zitat Gotch FA, Sargent JA (1985) A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 28:526–534CrossRefPubMed Gotch FA, Sargent JA (1985) A mechanistic analysis of the National Cooperative Dialysis Study (NCDS). Kidney Int 28:526–534CrossRefPubMed
50.
Zurück zum Zitat Eknoyan G, Beck GJ, Cheung AK et al (2002) Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347:2010–2019CrossRefPubMed Eknoyan G, Beck GJ, Cheung AK et al (2002) Effect of dialysis dose and membrane flux in maintenance hemodialysis. N Engl J Med 347:2010–2019CrossRefPubMed
51.
52.
Zurück zum Zitat Tattersall J, Farrington K, Gentile G et al (2018) Is Kt/V useful in elderly dialysis patients? Pro- and Con arguments. Nephrol Dial Transplant 33:742–750CrossRefPubMed Tattersall J, Farrington K, Gentile G et al (2018) Is Kt/V useful in elderly dialysis patients? Pro- and Con arguments. Nephrol Dial Transplant 33:742–750CrossRefPubMed
53.
Zurück zum Zitat Toth-Manikowski SM, Shafi T (2016) Hemodialysis prescription for incident patients: twice seems nice, but is it incremental? Am J Kidney Dis 68:180–183CrossRefPubMedPubMedCentral Toth-Manikowski SM, Shafi T (2016) Hemodialysis prescription for incident patients: twice seems nice, but is it incremental? Am J Kidney Dis 68:180–183CrossRefPubMedPubMedCentral
54.
Zurück zum Zitat Lowrie EG, Laird NM, Parker TF et al (1981) Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med 305:1176–1181CrossRefPubMed Lowrie EG, Laird NM, Parker TF et al (1981) Effect of the hemodialysis prescription of patient morbidity: report from the National Cooperative Dialysis Study. N Engl J Med 305:1176–1181CrossRefPubMed
55.
Zurück zum Zitat NKF-K/DOQI clinical practice guidelines for hemodialysis adequacy (2001) Update 2000. Am J Kidney Dis 37(Suppl 1):S7–S64 NKF-K/DOQI clinical practice guidelines for hemodialysis adequacy (2001) Update 2000. Am J Kidney Dis 37(Suppl 1):S7–S64
57.
Zurück zum Zitat Golper TA, Mehrotra R (2015) The intact nephron hypothesis in reverse: an argument to support incremental dialysis. Nephrol Dial Transplant 30:1602–1604CrossRefPubMed Golper TA, Mehrotra R (2015) The intact nephron hypothesis in reverse: an argument to support incremental dialysis. Nephrol Dial Transplant 30:1602–1604CrossRefPubMed
58.
Zurück zum Zitat Mathew AT, Fishbane S, Obi Y et al (2016) Preservation of residual kidney function in hemodialysis patients: reviving an old concept. Kidney Int 90:262–271CrossRefPubMedPubMedCentral Mathew AT, Fishbane S, Obi Y et al (2016) Preservation of residual kidney function in hemodialysis patients: reviving an old concept. Kidney Int 90:262–271CrossRefPubMedPubMedCentral
59.
Zurück zum Zitat Rhee CM, Unruh M, Chen J et al (2013) Infrequent dialysis: a new paradigm for hemodialysis initiation. Semin Dial 26:720–727CrossRefPubMed Rhee CM, Unruh M, Chen J et al (2013) Infrequent dialysis: a new paradigm for hemodialysis initiation. Semin Dial 26:720–727CrossRefPubMed
60.
Zurück zum Zitat Kalantar-Zadeh K, Unruh M, Zager PG et al (2014) Twice-weekly and incremental hemodialysis treatment for initiation of kidney replacement therapy. Am J Kidney Dis 64:181–186CrossRefPubMedPubMedCentral Kalantar-Zadeh K, Unruh M, Zager PG et al (2014) Twice-weekly and incremental hemodialysis treatment for initiation of kidney replacement therapy. Am J Kidney Dis 64:181–186CrossRefPubMedPubMedCentral
61.
62.
Zurück zum Zitat Fry AC, Singh DK, Chandna SM et al (2007) Relative importance of residual renal function and convection in determining beta-2-microglobulin levels in high-flux haemodialysis and on-line haemodiafiltration. Blood Purif 25:295–302CrossRefPubMed Fry AC, Singh DK, Chandna SM et al (2007) Relative importance of residual renal function and convection in determining beta-2-microglobulin levels in high-flux haemodialysis and on-line haemodiafiltration. Blood Purif 25:295–302CrossRefPubMed
64.
Zurück zum Zitat Masereeuw R, Mutsaers HA, Toyohara T et al (2014) The kidney and uremic toxin removal: glomerulus or tubule? Semin Nephrol 34:191–208CrossRefPubMed Masereeuw R, Mutsaers HA, Toyohara T et al (2014) The kidney and uremic toxin removal: glomerulus or tubule? Semin Nephrol 34:191–208CrossRefPubMed
65.
Zurück zum Zitat Leong SC, Sao JN, Taussig A et al (2018) Residual function effectively controls plasma concentrations of secreted solutes in patients on twice weekly hemodialysis. J Am Soc Nephrol 29:1992–1999CrossRefPubMedPubMedCentral Leong SC, Sao JN, Taussig A et al (2018) Residual function effectively controls plasma concentrations of secreted solutes in patients on twice weekly hemodialysis. J Am Soc Nephrol 29:1992–1999CrossRefPubMedPubMedCentral
66.
Zurück zum Zitat Shafi T, Jaar BG, Plantinga LC et al (2010) Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Am J Kidney Dis 56:348–358CrossRefPubMedPubMedCentral Shafi T, Jaar BG, Plantinga LC et al (2010) Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: the Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Am J Kidney Dis 56:348–358CrossRefPubMedPubMedCentral
67.
Zurück zum Zitat van der Wal WM, Noordzij M, Dekker FW et al (2011) Full loss of residual renal function causes higher mortality in dialysis patients; findings from a marginal structural model. Nephrol Dial Transplant 26:2978–2983CrossRefPubMed van der Wal WM, Noordzij M, Dekker FW et al (2011) Full loss of residual renal function causes higher mortality in dialysis patients; findings from a marginal structural model. Nephrol Dial Transplant 26:2978–2983CrossRefPubMed
68.
Zurück zum Zitat Vilar E, Wellsted D, Chandna SM et al (2009) Residual renal function improves outcome in incremental hemodialysis despite reduced dialysis dose. Nephrol Dial Transplant 24:2502–2510CrossRefPubMed Vilar E, Wellsted D, Chandna SM et al (2009) Residual renal function improves outcome in incremental hemodialysis despite reduced dialysis dose. Nephrol Dial Transplant 24:2502–2510CrossRefPubMed
69.
Zurück zum Zitat Marquez IO, Tambra S, Luo FJ et al (2011) Contribution of residual renal function to removal of protein-bound solutes in hemodialysis. Clin J Am Soc Nephrol 6:290–296CrossRefPubMedPubMedCentral Marquez IO, Tambra S, Luo FJ et al (2011) Contribution of residual renal function to removal of protein-bound solutes in hemodialysis. Clin J Am Soc Nephrol 6:290–296CrossRefPubMedPubMedCentral
70.
Zurück zum Zitat Menon MK, Naimark DM, Bargman JM et al (2001) Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function. Nephrol Dial Transplant 16:2207–2213CrossRefPubMed Menon MK, Naimark DM, Bargman JM et al (2001) Long-term blood pressure control in a cohort of peritoneal dialysis patients and its association with residual renal function. Nephrol Dial Transplant 16:2207–2213CrossRefPubMed
71.
Zurück zum Zitat Wang AY, Wang M, Woo J et al (2002) A novel association between residual renal function and left ventricular hyperthrophy in peritoneal dialysis patients. Kidney Int 62:639–647CrossRefPubMed Wang AY, Wang M, Woo J et al (2002) A novel association between residual renal function and left ventricular hyperthrophy in peritoneal dialysis patients. Kidney Int 62:639–647CrossRefPubMed
73.
Zurück zum Zitat NKF-K/DOQI clinical practice guidelines for hemodialysis adequacy (2006) Update 2006. Am J Kidney Dis 48(Suppl 1):S2–S90 NKF-K/DOQI clinical practice guidelines for hemodialysis adequacy (2006) Update 2006. Am J Kidney Dis 48(Suppl 1):S2–S90
74.
Zurück zum Zitat European Best Practice Guidelines Expert Group on Haemodialysis (2002) II.3 Haemodialysis dose and residual renal function (Kr). Nephrol Dial Transplant 17(Suppl 7):S24 European Best Practice Guidelines Expert Group on Haemodialysis (2002) II.3 Haemodialysis dose and residual renal function (Kr). Nephrol Dial Transplant 17(Suppl 7):S24
75.
76.
Zurück zum Zitat Neri L, Viglino G, Marinangeli G, on behalf of Peritoneal Dialysis Study Group of Italian Society of Nephrology et al (2017) Incremental start to PD as experienced in Italy: results of censuses carried out from 2005 to 2014. J Nephrol 30:593–599CrossRefPubMed Neri L, Viglino G, Marinangeli G, on behalf of Peritoneal Dialysis Study Group of Italian Society of Nephrology et al (2017) Incremental start to PD as experienced in Italy: results of censuses carried out from 2005 to 2014. J Nephrol 30:593–599CrossRefPubMed
77.
Zurück zum Zitat Basile C, Casino FG, Kalantar-Zadeh K (2017) Is incremental hemodialysis ready to return on the scene? From empiricism to kinetic modelling. J Nephrol 30:521–529CrossRefPubMed Basile C, Casino FG, Kalantar-Zadeh K (2017) Is incremental hemodialysis ready to return on the scene? From empiricism to kinetic modelling. J Nephrol 30:521–529CrossRefPubMed
79.
Zurück zum Zitat Wong J, Vilar E, Davenport A et al (2015) Incremental haemodialysis. Nephrol Dial Transplant 30:1639–1648CrossRefPubMed Wong J, Vilar E, Davenport A et al (2015) Incremental haemodialysis. Nephrol Dial Transplant 30:1639–1648CrossRefPubMed
80.
Zurück zum Zitat Lin YF, Huang JW, Wu MS et al (2009) Comparison of residual renal function in patients undergoing twice-weekly versus three-times-weekly haemodialysis. Nephrology 14:59–64CrossRefPubMed Lin YF, Huang JW, Wu MS et al (2009) Comparison of residual renal function in patients undergoing twice-weekly versus three-times-weekly haemodialysis. Nephrology 14:59–64CrossRefPubMed
81.
Zurück zum Zitat Obi Y, Streja E, Rhee CM et al (2016) Incremental hemodialysis, residual kidney function, and mortality risk in incident dialysis patients: a cohort study. Am J Kidney Dis 68:256–265CrossRefPubMedPubMedCentral Obi Y, Streja E, Rhee CM et al (2016) Incremental hemodialysis, residual kidney function, and mortality risk in incident dialysis patients: a cohort study. Am J Kidney Dis 68:256–265CrossRefPubMedPubMedCentral
82.
Zurück zum Zitat Singh S, Choi P, Power A et al (2013) Ten-year patient survival and maintenance haemodialysis: association with treatment time and dialysis dose. J Nephrol 26:763–770CrossRefPubMed Singh S, Choi P, Power A et al (2013) Ten-year patient survival and maintenance haemodialysis: association with treatment time and dialysis dose. J Nephrol 26:763–770CrossRefPubMed
83.
Zurück zum Zitat van Olden RW, van Acker BA, Koomen GC et al (1995) Time course of inulin and creatinine clearance in the interval between two haemodialysis treatments. Nephrol Dial Transplant 10:2274–2280CrossRefPubMed van Olden RW, van Acker BA, Koomen GC et al (1995) Time course of inulin and creatinine clearance in the interval between two haemodialysis treatments. Nephrol Dial Transplant 10:2274–2280CrossRefPubMed
85.
Zurück zum Zitat Casino FG, Lopez T (1996) The equivalent renal urea clearance: a new parameter to assess dialysis dose. Nephrol Dial Transplant 11:1574–1581CrossRefPubMed Casino FG, Lopez T (1996) The equivalent renal urea clearance: a new parameter to assess dialysis dose. Nephrol Dial Transplant 11:1574–1581CrossRefPubMed
86.
Zurück zum Zitat Tennekes HA, Sánchez-Bayo F (2013) The molecular basis of simple relationships between exposure concentration and toxic effects with time. Toxicology 309:39–51CrossRefPubMed Tennekes HA, Sánchez-Bayo F (2013) The molecular basis of simple relationships between exposure concentration and toxic effects with time. Toxicology 309:39–51CrossRefPubMed
87.
Zurück zum Zitat Casino FG, Basile C (2017) The variable target model: a paradigm shift in the incremental haemodialysis prescription. Nephrol Dial Transplant 32:182–190CrossRefPubMed Casino FG, Basile C (2017) The variable target model: a paradigm shift in the incremental haemodialysis prescription. Nephrol Dial Transplant 32:182–190CrossRefPubMed
88.
Zurück zum Zitat NKF-K/DOQI clinical practice guidelines for hemodialysis adequacy (2015) Update 2015. Am J Kidney Dis 66:884–930CrossRef NKF-K/DOQI clinical practice guidelines for hemodialysis adequacy (2015) Update 2015. Am J Kidney Dis 66:884–930CrossRef
89.
Zurück zum Zitat Vilar E, Farrington K (2011) Emerging importance of residual renal function in end-stage renal failure. Semin Dial 24:487–494CrossRefPubMed Vilar E, Farrington K (2011) Emerging importance of residual renal function in end-stage renal failure. Semin Dial 24:487–494CrossRefPubMed
90.
Zurück zum Zitat Casino FG, Basile C (2018) How to set the stage for a full-fledged clinical trial testing “incremental haemodialysis”. Nephrol Dial Transplant 33:1103–1109CrossRefPubMed Casino FG, Basile C (2018) How to set the stage for a full-fledged clinical trial testing “incremental haemodialysis”. Nephrol Dial Transplant 33:1103–1109CrossRefPubMed
91.
Zurück zum Zitat Casino FG, Basile C (2018) A user-friendly tool for incremental haemodialysis prescription. Nephrol Dial Transplant 33:1046–1053CrossRefPubMed Casino FG, Basile C (2018) A user-friendly tool for incremental haemodialysis prescription. Nephrol Dial Transplant 33:1046–1053CrossRefPubMed
94.
Zurück zum Zitat Fernández-Lucas M, on behalf of Fundation para la investigation biomedica del Hospital Universitario Ramon y Cajal, Madrid, Spain. Incremental hemodialysis as a starting way of renal replacement therapy. ClinicalTrials.gov Identifier NCT03302546 Fernández-Lucas M, on behalf of Fundation para la investigation biomedica del Hospital Universitario Ramon y Cajal, Madrid, Spain. Incremental hemodialysis as a starting way of renal replacement therapy. ClinicalTrials.gov Identifier NCT03302546
95.
Zurück zum Zitat Vilar E, on behalf of East and North Hertfordshire NHS Trust, Stevenage, UK. Does incremental initiation of haemodialysis preserve native kidney function? (Incremental HD). ClinicalTrials.gov Identifier NCT03418081 Vilar E, on behalf of East and North Hertfordshire NHS Trust, Stevenage, UK. Does incremental initiation of haemodialysis preserve native kidney function? (Incremental HD). ClinicalTrials.gov Identifier NCT03418081
96.
Zurück zum Zitat Courivaud C, on behalf of Centre Hospitalier Universitaire de Besancon, France. Quality of life of frail aged patients in incremental hemodialysis (Qualifragilys). ClinicalTrials.gov Identifier NCT03782519 Courivaud C, on behalf of Centre Hospitalier Universitaire de Besancon, France. Quality of life of frail aged patients in incremental hemodialysis (Qualifragilys). ClinicalTrials.gov Identifier NCT03782519
Metadaten
Titel
Incremental hemodialysis, a valuable option for the frail elderly patient
verfasst von
Carlo Basile
Francesco Gaetano Casino
Filippo Aucella
Publikationsdatum
01.10.2019
Verlag
Springer International Publishing
Erschienen in
Journal of Nephrology / Ausgabe 5/2019
Print ISSN: 1121-8428
Elektronische ISSN: 1724-6059
DOI
https://doi.org/10.1007/s40620-019-00611-4

Weitere Artikel der Ausgabe 5/2019

Journal of Nephrology 5/2019 Zur Ausgabe

Leitlinien kompakt für die Innere Medizin

Mit medbee Pocketcards sicher entscheiden.

Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag

Notfall-TEP der Hüfte ist auch bei 90-Jährigen machbar

26.04.2024 Hüft-TEP Nachrichten

Ob bei einer Notfalloperation nach Schenkelhalsfraktur eine Hemiarthroplastik oder eine totale Endoprothese (TEP) eingebaut wird, sollte nicht allein vom Alter der Patientinnen und Patienten abhängen. Auch über 90-Jährige können von der TEP profitieren.

Niedriger diastolischer Blutdruck erhöht Risiko für schwere kardiovaskuläre Komplikationen

25.04.2024 Hypotonie Nachrichten

Wenn unter einer medikamentösen Hochdrucktherapie der diastolische Blutdruck in den Keller geht, steigt das Risiko für schwere kardiovaskuläre Ereignisse: Darauf deutet eine Sekundäranalyse der SPRINT-Studie hin.

Bei schweren Reaktionen auf Insektenstiche empfiehlt sich eine spezifische Immuntherapie

Insektenstiche sind bei Erwachsenen die häufigsten Auslöser einer Anaphylaxie. Einen wirksamen Schutz vor schweren anaphylaktischen Reaktionen bietet die allergenspezifische Immuntherapie. Jedoch kommt sie noch viel zu selten zum Einsatz.

Therapiestart mit Blutdrucksenkern erhöht Frakturrisiko

25.04.2024 Hypertonie Nachrichten

Beginnen ältere Männer im Pflegeheim eine Antihypertensiva-Therapie, dann ist die Frakturrate in den folgenden 30 Tagen mehr als verdoppelt. Besonders häufig stürzen Demenzkranke und Männer, die erstmals Blutdrucksenker nehmen. Dafür spricht eine Analyse unter US-Veteranen.

Update Innere Medizin

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.